SCHEMBL9458484

SCHEMBL9458484

COCCOc1cc(N)c(Cl)cc1C(=O)OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.68
HTR4 Q13639 4/20 0.50
CYP3A4 P08684 3/20 0.50
CYP2D6 P10635 3/20 0.50
HTR3A P46098 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GLA P06280 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
SLC22A1 O15245 1/20 0.46
HTR3B O95264 1/20 0.46
LMNA P02545 1/20 0.46
MPO P05164 1/20 0.46
ADRA2A P08913 1/20 0.46
DRD2 P14416 1/20 0.46
ADRA2C P18825 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7265682 0.87 GAA (0.50) GAAHTR4CYP3A4CYP2D6HTR3A
SCHEMBL7267139 0.87 GAA (0.50) GAAHTR4CYP3A4CYP2D6HTR3A
SCHEMBL7373656 0.85 GAA (0.72) GAAHTR4CYP3A4CYP2D6HTR3A
SCHEMBL3470108 0.82 KDM4E (0.65) GAATSHRGLAKDM4EALDH1A1
SCHEMBL384749 0.82 GAA (1.00) GAAHTR4CYP3A4CYP2D6HTR3A
SCHEMBL7409017 0.81 GAA (0.65) GAAHTR4CYP3A4CYP2D6HTR3A
Hydrochloric Acid SCHEMBL7405359 0.80 GAA (0.97) GAAHTR4CYP3A4CYP2D6HTR3A
SCHEMBL8364917 0.80 GAA (0.63) GAAHTR4
SCHEMBL1012527 0.78 KDM4E (0.73) GAACYP1A2CYP2C9TSHRSMN1; SMN2
SCHEMBL1012713 0.78 KDM4E (0.73) GAACYP1A2CYP2C9TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5244907-A Treatment of serotonin imbalance, increase in gastric motility, antiemetics, antiarrhythmia agents A. H. ROBINS COMPANY, INCORPORATED (US) 1993-09-14 US disclosed
US-5236931-A Treating anxiety, psychosis, cognitive dysfunction, migrane, cluster headache, trigeminal neuralgia emesis and impaired gastric motility A. H. ROBINS COMPANY, INCORPORATED (US) 1993-08-17 US disclosed
US-5190953-A 1-azabicyclo(3.2.1.)octan-5-ylmethyl- or 1-azabicyclo(3.3.1) nonan-5-ylmethyl derivatives of carboxamides, thiocarboxamides or esters, thioesters A. H. ROBINS COMPANY, INCORPORATED (US) 1993-03-02 US disclosed
US-5137895-A Antiemetic, anxiolytic, gastric emptying and serotonin modulating activity A. H. ROBINS COMPANY, INCORPORATED (US) 1992-08-11 US disclosed